Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 6.493
Filtrar
1.
Rev Bras Epidemiol ; 23: e200048, 2020.
Artigo em Inglês, Português | MEDLINE | ID: mdl-32491045

RESUMO

INTRODUCTION: No studies were found that evaluate the association between intimate partner violence (IPV) before childbirth and sexual issues in the postpartum period. METHOD: A cross-sectional study with 700 women who received prenatal care in a basic health unit in São Paulo, between 2006 and 2007. Sexual issues were assessed through a questionnaire created by the authors, and intimate partner violence was evaluated using a structured questionnaire developed by the WHO. Postpartum depression was evaluated using the SRQ-20 instrument, with a cut-off point of 7/8 considered to be the mediating variable. A path analysis was performed to determine the different pathways: the direct association between outcome and exposure, and the indirect pathways through the mediator. RESULTS: The prevalence of sexual issues, intimate partner violence and postpartum depression were 30; 42.8; 27.8%, respectively. Violence occurring exclusively before childbirth did not show a direct association (ED = 0.072 (-0.06 - 0.20, p = 0.060)) or indirect (EI: 0.045 (-0.06 - 0.20, p = 0.123)), with sexual issues. CONCLUSION: Longitudinal studies that include other mediators may provide a better understanding of the causal chain and elucidate variables that influence postpartum sexuality issues.


Assuntos
Depressão Pós-Parto/psicologia , Violência por Parceiro Íntimo/psicologia , Período Pós-Parto/psicologia , Comportamento Sexual/psicologia , Adolescente , Adulto , Estudos Transversais , Feminino , Humanos , Autorrelato , Disfunções Sexuais Psicogênicas , Fatores Socioeconômicos , Fatores de Tempo , Adulto Jovem
2.
Eur J Endocrinol ; 182(6): R101, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32234976

RESUMO

Sexual function is an important component of either general health and quality of life in both genders. Many studies have focused on the different risk factors for sexual dysfunctions, proving an association with several medical conditions. Endocrine disorders have been often mentioned in the pathogenesis of female and male sexual dysfunctions; however, particularly in women, sexual function is rarely addressed during clinical, in general, and endocrinological, in particular, consultations. As a thorough diagnosis is required in order to provide an adequately tailored treatment, knowing how each endocrine dysfunction can impair sexual health is of the utmost importance, considering the high prevalence of conditions such as disorders of pituitary, thyroid, adrenal, gonads, as well as metabolic disorders. We performed a thorough review of existing literature on the different mechanisms involved in the pathogenesis of female sexual dysfunctions secondary to endocrine disorders in order to provide an up-to-date reference.


Assuntos
Disfunções Sexuais Fisiológicas/patologia , Disfunções Sexuais Psicogênicas/patologia , Gerenciamento Clínico , Doenças do Sistema Endócrino/complicações , Doenças do Sistema Endócrino/patologia , Feminino , Humanos , Disfunções Sexuais Fisiológicas/etiologia , Disfunções Sexuais Psicogênicas/etiologia
3.
Rev. Hosp. Ital. B. Aires (2004) ; 40(1): 34-38, mar. 2020. tab
Artigo em Espanhol | LILACS | ID: biblio-1102292

RESUMO

Las mujeres han sido tratadas por décadas con testosterona intentando aliviar una gran variedad de síntomas con riesgos y beneficios inciertos. En la mayoría de los países, la testosterona se prescribe "off-label", de modo que las mujeres están utilizando compuestos y dosis ideadas para tratamientos en hombres. En este sentido, varias sociedades médicas de distintos continentes adoptaron recientemente por consenso una toma de posición sobre los beneficios y potenciales riesgos de la terapia con testosterona en la mujer, explorar las áreas de incertidumbre e identificar prácticas de prescripción con potencial de causar daño. Las recomendaciones con respecto a los beneficios y riesgos de la terapia con testosterona se basan en los resultados de ensayos clínicos controlados con placebo de al menos 12 semanas de duración. A continuación se comentan las recomendaciones. (AU)


There are currently no clear established indications for testosterone replacement therapy for women. Nonetheless, clinicians have been treating women with testosterone to alleviate a variety of symptoms for decades with uncertainty regarding its benefits and risks. In most countries, testosterone therapy is prescribed off-label, which means that women are using testosterone formulations or compounds approved for men with a modified dose for women. Due to these issues, there was a need for a global Consensus Position Statement on testosterone therapy for women based on the available evidence from placebo randomized controlled trials (RCTs). This Position Statement was developed to inform health care professionals about the benefits and potential risks of testosterone therapy intended for women. The aim of the Consensus was to provide clear guidance as to which women might benefit from testosterone therapy; to identify symptoms, signs, and certain conditions for which the evidence does not support the prescription of testosterone; to explore areas of uncertainty, and to identify any prescribing practices that have the potential to cause harm. (AU)


Assuntos
Humanos , Feminino , Idoso , Testosterona/uso terapêutico , Pós-Menopausa/efeitos dos fármacos , Depressores do Apetite/efeitos adversos , Fenitoína/efeitos adversos , Placebos/administração & dosagem , Psicotrópicos/efeitos adversos , Tamoxifeno/efeitos adversos , Testosterona/administração & dosagem , Testosterona/análise , Testosterona/efeitos adversos , Testosterona/farmacologia , Fármacos Cardiovasculares/efeitos adversos , Indometacina/efeitos adversos , Hormônio Liberador de Gonadotropina/efeitos adversos , Pós-Menopausa/fisiologia , Ensaios Clínicos Controlados como Assunto , Antagonistas Colinérgicos/efeitos adversos , Anticoncepcionais Orais/efeitos adversos , Disfunções Sexuais Psicogênicas/etiologia , Disfunções Sexuais Psicogênicas/terapia , Danazol/efeitos adversos , Consenso , Inibidores da Aromatase/efeitos adversos , Uso Off-Label , Inibidores do Fator Xa/efeitos adversos , Anfetaminas/efeitos adversos , Antagonistas dos Receptores Histamínicos/efeitos adversos , Antagonistas de Androgênios/efeitos adversos , Androgênios/fisiologia , Cetoconazol/efeitos adversos , Entorpecentes/efeitos adversos
5.
Arch. med ; 20(1): 71-85, 2020-01-18.
Artigo em Espanhol | LILACS | ID: biblio-1053232

RESUMO

Objetivo: evaluar la eficacia y seguridad de dos terapias hormonales sustitutivas, combinadas con testosterona, en el tratamiento del trastorno del deseo sexual hipoactivo en mujeres en climaterio. Materiales y métodos: ensayo clínico, aleatorizado, controlado, no enmascarado. Se incluyeron mujeres mayores o igual a 40 años y menores de 60 años, con útero, con actividad sexual en las últimas seis semanas, aquejadas por síntomas vasomotores, cuyo motivo de co sulta consistió en bajo deseo sexual. Se utilizó como instrumento el cuestionario Índice de Función Sexual Femenina (IFSF). Se asignaron dos grupos aleatorizados: grupo «A¼ (51 recibieron estrógenos conjugados de equinos y edroxiprogesterona más testosterona) y grupo «B¼ (54 tibolona más testosterona). El estudio fue realizado entre julio de 2015 y diciembre de 2016, en Armenia, Quindío, Colombia. Resultados: se analizó una población de 105 mujeres. La media de edad fue de 55,8 (DS±9,38) años. En la población total, al inicio del estudio, la mediana fue de 3 encuentros sexuales por mes. Al final la mediana fue de 5 encuentros sexuales por mes, (grupo «A¼ 4 encuentros y grupo «B¼ 7 encuentros, p=0,0036). Al finalizar la investigación se observó que las mujeres del grupo «B¼, mostraron puntuaciones promedias significativamente más altas en el IFSF (28,56 DS±4,63 puntos), al compararlas con las mujeres del grupo «A¼ (27,57 DS±4,32) (p<0,0001). Conclusiones: la terapia con tibolona asociada a testosterona es una opción de tratamiento efectiva en el trastorno del deseo sexual hipoactivo en mujeres en climaterio..(AU)


Objective: to evaluate the efficacy and safety of two hormone replacement therapies, combined with testosterone, in the treatment of hypoactive sexual desire disorder in women in climacteric. Materials and methods: clinical trial, randomized, controlled, not masked. Women over 40 years old and under 60 years old, with a uterus, with sexual activity in the last six weeks, suffering from vasomotor symptoms, whose reason for consultation consisted of low sexual desire were included. The Female Sexual Function Index questionnaire was used as an instrument. Two randomized groups were assigned: group "A" (51 received conjugated estrogens from equines and medroxyprogesterone plus testosterone) and group "B" (54 tibolone plus testosterone). The study was conducted between July 2015 and December 2016, in Armenia, Quindío, Colombia. Results: a population of 105 women was analyzed. The average age was 55,8 (SD ± 9,38) years. In the total population, at the beginning of the study, the median was 3 sexual encounters per month. In the end, the median was 5 sexual encounters per month, (group «A¼ 4 meetings and group «B¼ 7 meetings, p = 0,0036). At the end of the investigation, it was observed that the women of the «B¼ group showed significantly higher average scores in the IFSF (28,56 SD ± 4,63 points), compared with values in the women of the «A¼ group (27,57 DS ± 4,32) (p<0,0001). Conclusions: testosterone-associated tibolone therapy is an effective treatment option in hypoactive sexual desire disorder in women in climacteric..(AU)


Assuntos
Feminino , Disfunções Sexuais Psicogênicas , Terapia de Reposição Hormonal
6.
PLoS One ; 15(1): e0227874, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-31995606

RESUMO

Medication adherence is a key health outcome that reflects the health and general well-being of patients with hypertension. Challenges with adherence are common and associated with clinical, behavioural and psychosocial factors. This study sought to provide data on the extent of medication adherence among male patients with hypertension and their biopsychosocial predictors. Patient and clinical characteristics, psychological distress, insomnia and sexual dysfunction were hypothesized to predict outcomes of medication adherence. Utilizing quantitative data from a hospital-based cross-sectional study from 358 male out-patients with hypertension attending a tertiary hospital in Ghana, medication adherence was associated with age, marital status, educational level, income, duration of diagnosis, number of medications taken and sexual dysfunction. These findings support the need for biopsychosocial interventions aiming at promoting adherence while taking these factors into consideration for the benefit of improving the health and general well-being of male patients with hypertension.


Assuntos
Hipertensão/epidemiologia , Adesão à Medicação , Disfunções Sexuais Psicogênicas/epidemiologia , Estresse Psicológico/epidemiologia , Adulto , Fatores Etários , Anti-Hipertensivos/efeitos adversos , Anti-Hipertensivos/uso terapêutico , Gana/epidemiologia , Humanos , Hipertensão/complicações , Hipertensão/psicologia , Masculino , Pessoa de Meia-Idade , Pacientes Ambulatoriais , Disfunções Sexuais Psicogênicas/etiologia , Disfunções Sexuais Psicogênicas/psicologia , Distúrbios do Início e da Manutenção do Sono/epidemiologia , Distúrbios do Início e da Manutenção do Sono/etiologia , Distúrbios do Início e da Manutenção do Sono/psicologia , Estresse Psicológico/etiologia , Estresse Psicológico/psicologia , Centros de Atenção Terciária
7.
Psychiatr Prax ; 47(1): 43-45, 2020 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-31284315

RESUMO

Hypersexual behavior can be assumed as a rare side effect of treatment with aripiprazole and is possibly due to partial agonism on dopamine receptors or partial agonism on 5-HT1A receptors and 5 HT2A antagonism.


Assuntos
Antipsicóticos , Aripiprazol , Comportamento Sexual , Disfunções Sexuais Psicogênicas/induzido quimicamente , Antipsicóticos/efeitos adversos , Antipsicóticos/uso terapêutico , Aripiprazol/efeitos adversos , Aripiprazol/uso terapêutico , Alemanha , Humanos , Receptor 5-HT1A de Serotonina , Receptor 5-HT2A de Serotonina , Antagonistas do Receptor 5-HT2 de Serotonina , Disfunções Sexuais Psicogênicas/psicologia
8.
Arthritis Care Res (Hoboken) ; 72(1): 41-62, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-30941870

RESUMO

OBJECTIVE: To systematically review evidence of the impact of inflammatory arthritis on, or association of inflammatory arthritis with, intimate relationships and sexual function. METHODS: Ovid Medline, Ovid PsycINFO, Ovid Embase, and EBSCO CINAHL databases were searched. Two independent reviewers selected articles, extracted data, and conducted manual searches of reference lists from included studies and previous reviews. The quality of evidence was assessed using standard risk-of-bias tools. RESULTS: Fifty-five eligible studies were reviewed. Of these, 49 (89%) were quantitative, 5 (9.1%) were qualitative, and 1 (1.8%) used a mixed-method design. Few quantitative studies were rated as low risk of bias (n = 7 [14%]), many were rated as moderate (n = 37 [74%]) or high risk (n = 6 [12%]). Quantitative study sample sizes ranged from 10 to 1,272 participants, with a reported age range 32-63 years. Qualitative study sample sizes ranged from 8 to 57 participants, with a reported age range 20-69 years. In studies reporting the Female Sexual Function Index, all inflammatory arthritis groups demonstrated mean scores ≤26.55 (range of mean ± SD scores: 14.2 ± 7.8 to 25.7 ± 4.7), indicating sexual dysfunction. In studies reporting the International Index of Erectile Function, all inflammatory arthritis groups reported mean scores ≤25 (range of mean ± SD scores: 16.0 ± 5.3 to 23.8 ± 7.0), indicating erectile dysfunction. Key qualitative themes were impaired sexual function and compromised intimate relationships; prominent subthemes included inflammatory arthritis-related pain and fatigue, erectile dysfunction, diminished sexual desire, and sexual function fluctuations according to disease activity. CONCLUSION: Sexual dysfunction appears highly prevalent among men and women with inflammatory arthritis, and increased clinician awareness of this impairment may guide provision of tailored education and support.


Assuntos
Artrite/psicologia , Relações Interpessoais , Comportamento Sexual , Disfunções Sexuais Psicogênicas/etiologia , Sexualidade , Artrite/complicações , Artrite/fisiopatologia , Humanos , Disfunções Sexuais Psicogênicas/fisiopatologia , Disfunções Sexuais Psicogênicas/psicologia
9.
Expert Opin Drug Saf ; 19(1): 1-8, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31855607

RESUMO

Introduction: Hypoactive sexual desire disorder (HSDD) is the most prevalent sexual dysfunction in women, previously managed with off-label therapies. Indicated for premenopausal women, flibanserin is the first FDA-approved medication to treat HSDD.Areas covered: This review summarizes flibanserin's pharmacokinetics, proposed mechanism of action, and safety data in clinical trials with a focus on sedation- and hypotension-related adverse events, and drug interactions with alcohol and antidepressants. Sources included peer-reviewed publications and internal data from the manufacturer.Expert opinion: Flibanserin is a well-tolerated and effective treatment that decreases distress and restores sexual desire to a level that is normative for the individual patient with HSDD. Simplification of a risk mitigation program for flibanserin in the US is likely to increase the number of prescribing clinicians if accompanied with educational efforts to clarify flibanserin's risk-benefit profile. As flibanserin is dosed daily and may be used for a decade or more in the typical premenopausal patient, long-term pharmacovigilance data will be essential. Over time, HSDD will be treated by more nonspecialist health care professionals and flibanserin will likely become established as a significant treatment option along with other medications approved for this indication in the context of a holistic biopsychosocial treatment paradigm.


Assuntos
Benzimidazóis/administração & dosagem , Pré-Menopausa , Disfunções Sexuais Psicogênicas/tratamento farmacológico , Benzimidazóis/efeitos adversos , Interações Medicamentosas , Humanos , Hipotensão/induzido quimicamente , Hipotensão/epidemiologia
10.
J Matern Fetal Neonatal Med ; 33(2): 222-229, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-29890872

RESUMO

Purpose: This descriptive and cross-sectional study aims to determine the sexual function status of primipar and multipar pregnant women who admitted to birth clinics in Iran, Turkey and Greece and to investigate the relationship between pregnancy processes and some variables.Methodology: This descriptive and cross-sectional study population consisted of primipar/multipar pregnant women who met the research inclusion criteria, agreed to participate in the research and admitted to the Tabriz Pars Clinic in Iran, Izmir Aegean Maternity Hospital in Turkey and Thessaloniki University Hospital in Greece.Results: When the sexual problems of women are compared according to their countries,it was determined that 40% of Iranian women "can't easily share their sexuality issues with their spouses", whereas this rate was 8% in Turkey and 6.7% in Greece.Considering the prevalence of orgasmic and arousal disorder in the pre-pregnancy period,it was reported that this rate was 53% in Iran, 47% in Greece and 5.6% in Turkey.In the study, the mean "Female Sexual Function Index(FSFI)" score of Turkish women was found to be (59.83 ± 21.75), whereas the FSFI score of Iranian women was (62.86 ± 22.71) and mean FSFI score of the Greek women was (54.33 ± 21.15).Discussion: In the study, it was shown that there is a difference in the sexual problems of the women, depending on the religious and socio-cultural structure of the country they live in. For an effective case and training on sexuality,the norms and values of the society have to be understood in order to raise quality of lives and problem-free sexuality of pregnant women.


Assuntos
Comportamento Sexual/estatística & dados numéricos , Disfunções Sexuais Fisiológicas/epidemiologia , Disfunções Sexuais Psicogênicas/epidemiologia , Adulto , Comparação Transcultural , Estudos Transversais , Feminino , Grécia/epidemiologia , Humanos , Irã (Geográfico)/epidemiologia , Masculino , Gravidez , Cônjuges , Turquia/epidemiologia
11.
Diagn. tratamento ; 24(4): [170-173], out - dez. 2019.
Artigo em Português | LILACS | ID: biblio-1049394

RESUMO

Casais tendem a um declínio do interesse sexual, mais intenso na população feminina, acompanhado de menor satisfação conjugal. Mindfulness, ou consciência plena, é um estado caracterizado pela atenção centrada no momento. Possíveis mecanismos que tornam essa prática eficaz incluem: maior satisfação relacional, melhora na imagem corporal, maior consciência interoceptiva, diminuição do humor deprimido e da ansiedade. O treinamento na prática mindfulness baseia-se em oito sessões de grupo em que se associam diferentes procedimentos para a consciência corporal, tais como o escaneamento corporal, a respiração com atenção, a caminhada meditativa e os exercícios de compaixão e autocompaixão. Intervenções baseadas em mindfulness estimulam o foco nas sensações de excitação, o que pode melhorar a função sexual. A prática mindfulness desempenha papel importante no aumento da satisfação com o relacionamento conjugal e na habilidade do indivíduo em responder com menos emocionalidade ao estresse, além de favorecer a percepção positiva da relação, por melhorar a qualidade da comunicação durante uma interlocução. Atenção plena pode ajudar a amenizar interferências cognitivas durante a atividade sexual. O aumento da consciência corporal facilita a regulação emocional e comportamentos mais intencionais. A prática mindfulness atua nas barreiras psicológicas para uma experiência sexual satisfatória, diminuindo distrações relacionadas ao corpo e ao desempenho e melhorando a autoimagem genital, condições que favorecem a consciência interoceptiva e a satisfação conjugal.


Assuntos
Casamento , Disfunções Sexuais Psicogênicas , Saúde Sexual , Atenção Plena
12.
BMC Endocr Disord ; 19(1): 141, 2019 Dec 18.
Artigo em Inglês | MEDLINE | ID: mdl-31852461

RESUMO

BACKGROUND: Diabetes mellitus causes multiple medical, psychological and sexual problems in both men and women. Sexual dysfunction is one of those problems that lead to a strong social and psychological problem which adversely affect marital relation and treatment outcome. The issue has not been well studied in Ethiopia; therefore, this study aimed to evaluate the prevalence and factors related to sexual dysfunction in adult patients with diabetes mellitus. METHODS: Facility-based cross-sectional study was conducted among adults with diabetes mellitus on follow-up at diabetic clinics of Mizan-Tepi University Teaching Hospital and Tepi General Hospital. A consecutive sampling technique was employed to select 423 study participants, and data were collected through interviewer-administered questionnaire and patients' medical chart review. Changes in Sexual Functioning Questionnaire-fourteen items (CSFQ-14) was used to measure sexual dysfunction. Descriptive statistics and binary logistic regression analyses were performed. Two tail tests at α of less 0.05 were used as a level of significance. RESULTS: A total of 398 diabetic patients were interviewed, with a 94% response rate. The prevalence of sexual dysfunction was 53.3%. Age of above 41 years (AOR: 3.98, 95% CI 2.32-6.85), lack of formal education (AOR: 3.20, 95% CI 1.60-6.39), divorced or widowed (AOR: 5.28, 95% CI 2.35-11.86), type 2 DM (AOR: 4.52, 95% CI 2.17-9.42), depression (AOR: 4.05, 95% CI 2.32-7.10), complications or co-morbidity (AOR: 2.05, 95% CI 1.18-3.58), and not doing physical activity (AOR: 1.62, 95% CI; 1.47-1.77) were significantly associated with sexual dysfunction among diabetes patients. CONCLUSIONS: The prevalence of sexual dysfunction was as high as reports from other studies. Therefore, health care providers should include the issue of sexual health in their routine discussions with adult diabetes mellitus patients. Presence of depression, not doing physical activity and having complications or co-morbidity are modifiable factors associated with sexual dysfunction; therefore, they should be attended during care addressing sexual dysfunction.


Assuntos
Complicações do Diabetes/epidemiologia , Diabetes Mellitus/epidemiologia , Disfunções Sexuais Fisiológicas/epidemiologia , Disfunções Sexuais Psicogênicas/epidemiologia , Adolescente , Adulto , Estudos Transversais , Etiópia/epidemiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Fatores de Risco , Inquéritos e Questionários , Adulto Jovem
13.
Rev. int. androl. (Internet) ; 17(4): 130-137, oct.-dic. 2019. tab, graf
Artigo em Inglês | IBECS | ID: ibc-189270

RESUMO

INTRODUCTION: The links between body weight and sexuality, notably sexual dysfunction (SD), are intricate and not yet fully understood. A more individual-focused evaluation of sexual difficulties, as recently provided by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), contributes to improve precision in SD diagnosis and has the potential to advance our knowledge on the association between body weight and SD. OBJECTIVES: To identify gender differences in sexual behaviors and SD among Portuguese men and women within different classes of body mass index (BMI); and to explore the association between BMI and SD by using the new DSM-5 criteria. MATERIAL AND METHODS: Face-to-face interviews followed by self-completed questionnaires of primary healthcare users in Portugal (n=323). Data on sociodemographic variables, BMI, sexual behaviors and SD were collected. DSM-5 criteria were used to assess sexual dysfunction. The International Index of Erectile Function (IIEF) and the Female Sexual Function Index (FSFI) for men and women, respectively, were used for comparison purposes. RESULTS: Overweight and obese women reported less sexual partners, less satisfaction with sexual frequency and rated sexual life as less important. These differences were not found among men. Normal weight men and women had a higher score of IIEF and FSFI, respectively, than those overweight and obese. No significant effects of BMI scale on SD following DMS-5 were detected. CONCLUSIONS: Women's sexual function is more impacted by BMI than men's. Individual-orientated approaches, as proposed in DSM-5, may allow a better understanding on the relation between body size and sexuality in both genders


INTRODUCCIÓN: La relación entre el peso corporal y la sexualidad, en particular la disfunción sexual (DS), es compleja y aún no se entiende por completo. Una evaluación de las dificultades sexuales más centrada en el individuo, como la recientemente proporcionada por el Manual Diagnóstico y Estadístico de los Trastornos Mentales (DSM-5), contribuye a mejorar la precisión en el diagnóstico de la DS y tiene el potencial para avanzar en el conocimiento sobre la asociación entre el peso corporal y la DS. OBJETIVO: Identificar diferencias de género en conductas sexuales y DS entre varones y mujeres portuguesas con diferentes clases de índice de masa corporal (IMC), y explorar la asociación entre IMC y DS utilizando los nuevos criterios del DSM-5. MATERIAL Y MÉTODOS: Entrevistas cara a cara con usuarios de atención primaria de salud en Portugal (n=323), seguidas de cuestionarios autocompletados. Se recogieron datos sobre variables sociodemográficas, IMC, conductas sexuales y DS. Los criterios del DSM-5 se utilizaron para evaluar la DS. El Índice Internacional de Función Eréctil (IIEF) y el Índice de Función Sexual Femenina (IFSF) se utilizaron con fines comparativos, para varones y mujeres, respectivamente. RESULTADOS: Las mujeres con sobrepeso y obesidad comunicaron menos parejas sexuales, menor satisfacción con la frecuencia sexual y calificaron la vida sexual como menos importante. Estas diferencias no se encontraron entre los varones. Los varones y mujeres de peso normal tuvieron una puntuación más alta de IIEF y IFSF, respectivamente, que los varones y las mujeres con sobrepeso y obesidad. No se detectaron efectos importantes de la escala del IMC en la DS según el DSM-5. CONCLUSIÓN: La función sexual de las mujeres está más afectada por el IMC que la de los varones. Los enfoques orientados al individuo, como se propone en el DSM-5, pueden permitir una mejor comprensión de la relación entre el peso corporal y la sexualidad en ambos sexos


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Índice de Massa Corporal , Manual Diagnóstico e Estatístico de Transtornos Mentais , Comportamento Sexual/psicologia , Disfunções Sexuais Psicogênicas/diagnóstico , Fatores Sexuais
14.
Niger J Clin Pract ; 22(11): 1553-1563, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31719277

RESUMO

Background: Premature ejaculation (PE) is a sexual dysfunction causing female sexual dissatisfaction that eventually leads to poor quality of life in both partners. Aims: To show the presence of depression, anxiety, sexual function disorders and their prevalence in spouses of males with PE living in Eastern Turkey. Materials and Methods: Ninety male patients suffering from PE who referred to the andrology clinic between January 2016 and March 2017 and diagnosed with PE (Acquired Premature ejaculation) according to the DSM-IV criteria and their partners were included in the study. Male patients answered the PE Profile, Arabic Index of PE, PE Diagnostic Tool, and Arizona Sexual Experiences Scale (ASEX) Questionnaires. Spouses of male patients with PE answered the Arizona Sexual Experiences Scale, Beck Depression Inventory, and Beck Anxiety Inventory Questionnaires. SPSS software version 21.0 was used for statistical analysis. Results: Our study revealed a positive correlation between the PE profile and partners' depression levels (P = 0.03). Also, the average ASEX Scale score of the both genders suggest that patients and partners believe they did not have a severe sexual function disorder. Conclusions: PE can cause psychological problems in both males and females. However, reflection of this pathology can vary from one society to another.


Assuntos
Ejaculação Precoce/psicologia , Qualidade de Vida , Comportamento Sexual/psicologia , Disfunções Sexuais Psicogênicas/epidemiologia , Parceiros Sexuais/psicologia , Sexualidade/psicologia , Adulto , Ansiedade/etiologia , Depressão/epidemiologia , Depressão/etiologia , Depressão/psicologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Ejaculação Precoce/epidemiologia , Prevalência , Comportamento Sexual/estatística & dados numéricos , Disfunções Sexuais Psicogênicas/psicologia , Estresse Psicológico , Inquéritos e Questionários , Turquia/epidemiologia
15.
BMC Womens Health ; 19(1): 137, 2019 11 14.
Artigo em Inglês | MEDLINE | ID: mdl-31727041

RESUMO

BACKGROUND: Female sexual dysfunction (FSD) is increasingly being identified as a problem around the world. Women can have problems in various parts of the sexual cycle - desire, arousal, lubrication, orgasm or they may experience pain related to sexual activity. The only study involving Singapore with regard to sexual dysfunction in women, the Asian Global Studies of Sexual Attitudes and Behaviours in 2002, reported that Singapore had one of the lowest age-standardised sexual dysfunction rates of 32% compared with other Asian countries. This pilot study aims to evaluate the prevalence of female sexual dysfunction and to investigate the independent significant risk factors among allied health workers in a tertiary hospital in Singapore. METHODS: A cross-sectional study where an anonymous questionnaire which included 19 questions in the FSFI (Female Sexual Function Index) was distributed to all allied health workers in a tertiary hospital in Singapore aged between 18 to 70 years old. RESULTS: Three hundred thirty completed questionnaires were involved in analysis. 56.0% of women were found to have sexual dysfunction. A significant difference was found in the prevalence of FSD when comparing nurses to other allied health staff, where nurses had a decreased risk of developing FSD. Age was not found to be a significant risk factor in our study. Respondents below 40 years of age had significantly lower satisfaction scores than those above 40. Indians and Filipinos were found to have lower scores than the Chinese and Malay respondents in the lubrication (p = 0.02) and pain domains (p = 0.02). CONCLUSION: A significant proportion our female allied health workers suffer from sexual dysfunction. In this study, we found that the overall prevalence was independent of age, race and marital status. Nurses had a lower risk of developing FSD. We will need further studies to assess the prevalence of female sexual dysfunction in the general population, to evaluate the independent significant risk factors for developing FSD, in addition to classical risk factors, as well as to assess the psychological impact of this condition and whether people would be willing to seek help for such problems.


Assuntos
Pessoal Técnico de Saúde/estatística & dados numéricos , Doenças Profissionais/epidemiologia , Disfunções Sexuais Fisiológicas/epidemiologia , Disfunções Sexuais Psicogênicas/epidemiologia , Adolescente , Adulto , Idoso , Estudos Transversais , Feminino , Humanos , Pessoa de Meia-Idade , Projetos Piloto , Prevalência , Fatores de Risco , Singapura/epidemiologia , Inquéritos e Questionários , Centros de Atenção Terciária , Adulto Jovem
16.
Tunis Med ; 97(5): 704-710, 2019 May.
Artigo em Inglês | MEDLINE | ID: mdl-31729744

RESUMO

INTRODUCTION: The birth of a child is a milestone in a woman's life. Sexual health concerns are common in postpartum as women face psychological and physical difficulties. However, studies about sexuality during postpartum are rare in Tunisia. AIM: To evaluate the sexual function of a population of women in postpartum, and identify possible particularities and associated factors of the studied population. METHODS: This was a cross-sectional, descriptive study of women who gave birth in the six months preceding the study. A questionnaire was sent viaa social networking service. RESULTS: Our population of 100 women had an average age of 31.4 years. Women lived in urban areas, were married, have gone to university, were mostly primiparous (73%), and had vaginal delivery (53%). The average time to have sex again after delivery was nine weeks. In postpartum, sexuality showed modifications such as a change in sexual practices and a decreased frequency of sexual intercourse (73% of cases). Some factors influenced the resumption of sexuality, such as instrumental vaginal delivery, breastfeeding, body image disturbances (37%), fatigue (24%) and lack of availability (60%). The major sexual dysfunctions reported during postpartum were: desire disorders (31%), altered vaginal lubrication (31%), painful intercourse (14%) and decreased sexual satisfaction (33%). CONCLUSION: Our study highlights the importance of identifying the sexual disturbances faced by women during postpartum.


Assuntos
Período Pós-Parto , Disfunções Sexuais Fisiológicas/epidemiologia , Disfunções Sexuais Psicogênicas/epidemiologia , Adulto , Estudos Transversais , Autoavaliação Diagnóstica , Feminino , Humanos , Sexualidade/fisiologia , Tunísia , Adulto Jovem
17.
Afr J Prim Health Care Fam Med ; 11(1): e1-e9, 2019 Oct 16.
Artigo em Inglês | MEDLINE | ID: mdl-31714117

RESUMO

BACKGROUND: Female sexual function (FSD) is a complex phenomenon. It integrates all body systems and is influenced by a variety of factors. Contraceptives have shown to have variable effects on FSD. In Kenya, the majority of women use hormonal contraception with high rates of discontinuation of use, attributed to related side effects such as weight loss and loss of libido. AIM: To determine the prevalence of and the factors affecting FSD among women using contraception in our setting. SETTING: The study was carried out at the Aga Khan University Hospital, Nairobi, at various clinical sites. METHODS: A cross-sectional study was conducted. Consecutive sampling of women of reproductive age using either hormonal or non-hormonal contraception was conducted. Two questionnaires were completed after obtaining informed consent. Independent associations of factors with the outcome variables were assessed using the chi-square test of association, and variables with a p 0.25 were used in the multivariate analysis. Factors associated with FSD were determined using binary logistic regression. RESULTS: A total of 566 participants were included. The prevalence of FSD among those using hormonal and those using non-hormonal contraception was 51.5% and 29.6%, respectively (p 0.0001). We found that the factors associated with FSD were presence of chronic illness and use of chronic medication, being self-employed or unemployed, alcohol intake and history of miscarriage(s). CONCLUSION: There was a high prevalence of and a strong association between hormonal contraception and FSD. More studies on this topic in different settings are recommended to investigate the effect of each type of hormonal method on FSD.


Assuntos
Anticoncepção/efeitos adversos , Disfunções Sexuais Fisiológicas , Disfunções Sexuais Psicogênicas , Adulto , Anticoncepção/métodos , Estudos Transversais , Feminino , Humanos , Quênia/epidemiologia , Pessoa de Meia-Idade , Análise Multivariada , Prevalência , Fatores de Risco , Disfunções Sexuais Fisiológicas/epidemiologia , Disfunções Sexuais Fisiológicas/etiologia , Disfunções Sexuais Psicogênicas/epidemiologia , Disfunções Sexuais Psicogênicas/etiologia , Inquéritos e Questionários
18.
BMC Womens Health ; 19(1): 133, 2019 11 07.
Artigo em Inglês | MEDLINE | ID: mdl-31699074

RESUMO

BACKGROUND: Cerebellar ataxia affects individuals in reproductive age. To date, few clinical cases of cerebellar ataxia and involvement of the cerebellum in sexual response were reported. We report a case of a woman that need to restore skills related for execution of sexual activity and coordination of movements during sexual intercourse. CASE PRESENTATION: We present a case of idiopathic cerebellar ataxia in a 25-year-old woman who was referred for sexual health consultation. The patient complained of sexual problems as follows: "I forgot the behaviors that I should adopt in a sexual encounter, and I know what to do only after paying attention to my movements." The history of sexual behavior indicated that this patient presented a "romantic love" model. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) reports that this condition involves anorgasmia disorder and female sexual arousal disorder. In addition, there was a loss of automatism and coordination of movements in the pelvis and lower extremities. The patient's condition improved with occupational and physical therapy combined with rehabilitation therapy based on cognitive behavioral criteria for sexual therapy. CONCLUSIONS: The case evolved from the romantic-affective model to a realistic model. The patient reported being comfortable during sexual intercourse and could explain her sexual needs to her partner. She managed to coordinate lower limb and pelvic movements, but did not reach an orgasm. Moreover, vaginal lubrication occurred with a time lag of 15-30 min after the end of sexual intercourse or masturbation.


Assuntos
Ataxia Cerebelar/complicações , Coito/psicologia , Disfunções Sexuais Fisiológicas/psicologia , Disfunções Sexuais Psicogênicas/psicologia , Adulto , Feminino , Humanos , Comportamento Sexual/psicologia
19.
Rev Bras Ginecol Obstet ; 41(11): 660-667, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31745959

RESUMO

OBJECTIVE: The incidence of obesity, which is a chronic condition, has increased in recent years. The association between obesity and female sexual dysfunction remains unclear, particularly in postmenopausal women. In the present study, we evaluated whether obesity is a risk factor for sexual dysfunction in postmenopausal women. METHODS: This is a cross-sectional study that analyzed data from interviews of postmenopausal women at the Climacteric Outpatient Clinic from 2015 to 2018. After applying the inclusion and exclusion criteria, 221 women aged between 40 and 65 years old were selected and invited to participate in the study. Obesity was diagnosed according to body mass index (BMI). The participants were grouped into the following BMI categories: group 1, 18.5-24.9 kg/m2 (normal); group 2, 25.0-29.9 kg/m2 (overweight); and group 3, ≥30.0 kg/m2 (obese). Sexual function was assessed using the Female Sexual Function Index (FSFI) questionnaire. Cutoff points of ≥23 and ≥26.5 were adopted to define a diagnosis of female sexual dysfunction (FSD) based on the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision by the American Psychiatric Association (DSM-IV-TR). RESULTS: The desire and arousal scores were statistically higher in the normal BMI group than in the obese group (p = 0.028 and p = 0.043, respectively). The satisfaction scores were statistically higher in the normal BMI group than in the overweight and obese groups (p < 0.05). The total FSFI score statistically differed among the BMI categories (p = 0.027). CONCLUSION: In the present study, obese and overweight postmenopausal women had higher total scores than women with normal BMI. Our results show that obese and overweight postmenopausal women had a higher index of dysfunction in desire and arousal and lower sexual satisfaction than normal-weight women.


Assuntos
Obesidade/fisiopatologia , Obesidade/psicologia , Pós-Menopausa/fisiologia , Disfunções Sexuais Fisiológicas/epidemiologia , Disfunções Sexuais Psicogênicas/epidemiologia , Adulto , Índice de Massa Corporal , Brasil/epidemiologia , Estudos Transversais , Feminino , Humanos , Pessoa de Meia-Idade , Fatores de Risco
20.
Seizure ; 73: 64-74, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31759295

RESUMO

PURPOSE: Women with epilepsy (WWE) frequently experience sexual problems, including sexual dysfunction and sexual distress. Therefore, this study aimed to examine the efficacy of a mindfulness-based cognitive therapy for sexuality (MBCT-S) on sexual function and intimacy among older adult WWE in Iran. METHODS: A multicenter randomized controlled trial was conducted at 15 neurology clinics in three Iranian cities. WWE together with their partners and healthcare providers were randomly assigned in patient and partner (PP; n = 220), patient, partner, and healthcare provider (PPHP; n = 220), or treatment as usual (TAU; n = 220) group. WWE and their partners in both the PP and PPHP groups received eight weeks of MBCT-S sessions. In the PPHP group, three individual sessions on sexual counseling were added for healthcare providers. Self-assessment scales were used at baseline, one month and six months after completing the intervention. Mixed linear regression models were developed to determine differences among the three groups. Multilevel mediation analyses were conducted to understand the mediating effects of mindfulness, intimacy, patient-physicians relationship and sexual counseling barriers. RESULTS: Improvements in sexual function, sexual distress, and intimacy were found in both the PP and PPHP groups at one-month and six-month follow-ups. The PPHP group compared with the PP group had greater improvement in intimacy at both follow-ups. Regarding sexual function, the PPHP group performed better than the PP group at the six-month follow-up. CONCLUSIONS: The MBCT-S appears efficacious in enhancing sexual function and reducing sex-related distress in Iranian older adult WWE. Future studies should examine its efficacy in other populations.


Assuntos
Epilepsia/complicações , Atenção Plena/métodos , Disfunções Sexuais Fisiológicas/terapia , Disfunções Sexuais Psicogênicas/terapia , Idoso , Terapia Cognitivo-Comportamental/métodos , Feminino , Humanos , Pessoa de Meia-Idade , Disfunções Sexuais Fisiológicas/etiologia , Disfunções Sexuais Psicogênicas/etiologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA